<DOC>
	<DOCNO>NCT02245464</DOCNO>
	<brief_summary>The objective PMS study monitor assess safety Micardis tablets patient hypertension period 6 year</brief_summary>
	<brief_title>Post Marketing Surveillance ( PMS ) Study Assess Safety Efficacy Micardis Patients With Essential Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<criteria>Male female patient diagnose essential hypertension Patients without prior experience Micardis tablet Known hypersensitivity Micardis tablet Pregnancy breastfeed Biliary atresia Severe hepatic failure patient Severe renal failure patient</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>